Moleculin Biotech, Inc.
MBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,853 | $25,446 | $30,321 | $49,989 |
| - Cash | $4,278 | $23,550 | $43,145 | $70,903 |
| + Debt | $478 | $574 | $451 | $159 |
| Enterprise Value | $2,053 | $2,470 | -$12,373 | -$20,755 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$26,515 | -$29,504 | -$30,510 | -$22,804 |
| % Margin | – | – | – | – |
| Net Income | -$21,763 | -$29,769 | -$29,025 | -$15,894 |
| % Margin | – | – | – | – |
| EPS Diluted | -158 | -376.75 | -380.5 | -221.75 |
| % Growth | 58.1% | 1% | -71.6% | – |
| Operating Cash Flow | -$23,862 | -$24,101 | -$27,639 | -$18,951 |
| Capital Expenditures | -$13 | -$124 | -$67 | -$19 |
| Free Cash Flow | -$23,875 | -$24,225 | -$27,706 | -$18,970 |